SAI - Detailed view

VORICONAZOL Pfizer Trockensub 200 mg Durchstf

Drug

Name

Voriconazol Pfizer, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Field of application

Pilzinfektionen

ATC

J02AC03 - VORICONAZOLE

08.06.0. – antifungals

Use

HAM – Human medicine

pharmaceutical form

PULPI – powder for concentrate for solution for infusion

Remedy code

S – synthetic products for human use

Dispensing categories

A – Dispensed once only on prescription by a physician or veterinarian (A)

Authorisation status

Z – approved

Authorisation category

C – NA Co-Marketing

Authorisation number

65770

Basic authorisation number

55945

Initial registration date

4/24/2015

Expiry date

12/31/9999

Dosage strength

Name

Voriconazol Pfizer 200 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Field of application

Pilzinfektionen

Dosage strength number

Authorisation status

Z – approved

Package

GTIN**

7680657700015

Trade status*

In trade from / since 4/24/2015

Status

A/R – Authorised / referenced

Package size

1 vial(s)

Package code

001

Authorisation status

Z – approved

Declaration

Component

Active substance

0.2 g voriconazolum

Excipient

3.2 g sulfobutylbetadexum natricum
0.221 g natrium

Spezialitätenliste***

Status

Date of deletion

Compulsory until

Public price (CHF)

161.00

Limitation points

None

Limitation

SB Deductible

10%

Generic

Yes

Authorisation holder

GLN**

7601001010604

Address

Pfizer AG
Schärenmoosstrasse 99
8052 Zürich (ZH)

Date of revision of the text

4/29/2025

Information for prof.

Leaflet

Report error

Data source: Swissmedic, *authorisation holder, **Refdata foundation, ***FOPH.